Eudaimonia Partners’s Imunon IMNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$139K Hold
767
0.03% 377
2021
Q2
$191K Sell
767
-1
-0.1% -$236 0.04% 370
2021
Q1
$207K Buy
768
+129
+20% +$43.3K 0.04% 328
2020
Q4
$89K Buy
639
+102
+19% +$12.2K 0.02% 476
2020
Q3
$77K Buy
537
+103
+24% +$26K 0.02% 460
2020
Q2
$316K Hold
434
0.12% 177
2020
Q1
$77K Buy
434
+178
+70% +$44.6K 0.03% 379
2019
Q4
$86K Buy
+256
New +$77.7K 0.03% 377

Other funds holding IMNN

Eudaimonia Partners's IMNN Position: Q3 2021 in Review

Eudaimonia Partners held its Imunon (IMNN) position steady in Q3 2021 at 767 shares worth $139K. The position accounts for 0.03% of the portfolio, ranked #377.

Eudaimonia Partners first reported a position in IMNN in Q4 2019 and has held it in 8 quarters since. The position peaked at $316K in Q2 2020. 37 funds tracked by Wall St. Rank hold IMNN as of Q3 2021.

  • Eudaimonia Partners held 767 shares of Imunon worth $139K as of Q3 2021.
  • Eudaimonia Partners left its Imunon share count unchanged in Q3 2021.
  • Imunon made up 0.03% of Eudaimonia Partners's portfolio in Q3 2021, its #377 holding.
  • Eudaimonia Partners first reported a position in Imunon in Q4 2019 and has held it in 8 quarters since.
  • Eudaimonia Partners's Imunon position peaked at $316K in Q2 2020.
  • 37 funds tracked by Wall St. Rank held Imunon as of Q3 2021.

Based on Eudaimonia Partners's 13F filing for Q3 2021, filed 25 Oct 2021.